or search for allinseo plug in" Body Health Advisor » Blog Archive » Advice on Health and Body Matters

News: Human body strongly resists Losing Weight

Research confirming the human body is designed to strongly resist attempts to lose weight was presented at an international gathering of obesity experts hosted by Queensland University of Technology.

Queensland University of Technology appetite regulation and energy balance researcher Dr Neil King, from the Institute of Health and Biomedical Innovation (IHBI), has discovered that human bodies have strong mechanisms to defend attempts to lose weight but very weak mechanisms to prevent weight gain.
Dr King’s weight loss intervention studies demonstrate the ‘plateau effect’, whereby weight loss from exercise and calorie restrictions stops at a certain point.
He conducted two studies on weight loss following induced energy deficits in two different groups of overweight and obese people. Dr King expressed that the ‘plateau effect’ has been known about for some time and weight management consultants recommend longer exercise times, higher intensity or cross training to combat it. But these studies show that a plateau in body weight occurs even in the face of a continued negative energy balance.
In the first study, 30 obese men and women took part in a 12-week, laboratory-based exercise program in which they exercised five times a week. The second study looked at weight loss in 200 males on a commercial weight loss program comprising exercise and dietary advice.
In the first study, the subjects’ energy deficit was caused by exercise only which was fixed and imposed in contrast to the second study where subjects used diet and exercise to lose weight but chose how much they did of each. Dr King stated that the first group’s weight loss during the first eight weeks averaged 3 kg but it ‘plateaued’ at week eight and weight loss for the next four weeks was markedly reduced (7 kg).
The second group had a variable pattern of weight loss but it, too, showed a plateau. He commented that there appears to be little at this stage to predict the onset, duration and frequency of the plateau. Dr King aims to identify and characterize mechanisms responsible for the human body’s inbuilt weight loss resistance.

Technorati Tags: , , ,

Tags: , , , , , , , , , , , , , , , , , , , , , , , , ,

Leave a Reply

  • A possible replacement of Rosiglitazone and Pioglitazone for Type II Diabetes?
    Findings from the Phase II SYNCHRONY study show that aleglitazar, a treatment for Type 2 diabetes, could be safe and effective and thus will be entered into Phase III trials. The data, already published online and forthcoming in The Lancet, were presented at the recent American Diabetes Association meeting in New Orleans, La. Aleglitazar is in [...]
  • New Hope for Type II Diabetics
    GlaxoSmithKline in February announced initiation and dosing of the first patient of the Phase III clinical trial programme to evaluate the efficacy, safety, and tolerability of the investigational GLP-1 (Glucagon-like peptide 1) agonist Syncria® (albiglutide) in men and women with type 2 diabetes. The Phase III program will include more than 4,000 patients […]
  • New Studies on Weight Loss Drug - promising results
    I know that many chronic obese people rely on Weight loss drugs to control their weight. No doubt despite the side effects, some people have really tried everything to natuarally lose weight, but to no avail. With a doctor’s advice, they resort to medication. These naturally come with side effects, and sometimes are not even [...]
  • Warning about Venom HYPERDRIVE 3.0 supplements
    FDA Warns Consumers Against Dietary Supplement Containing Undeclared Drug Product poses safety risk The U.S. Food and Drug Administration is warning consumers not to take Venom HYPERDRIVE 3.0, a product sold as a dietary supplement and containing sibutramine. Sibutramine, a controlled substance with risks for abuse or addiction, is a potent drug [...]
Pages
H1N1 Fraudulent Products update







Tai Chi WeightLoss